Download Invited Speaking Engagements, Presentations, Symposia

James B. Yu MD MHS
CURRICULUM VITAE
Date of Revision:
July 28, 2015
Name:
James B. Yu MD, MHS
Education:
B.S.
M.D.
M.H.S.
Yale University (Physics) 1999
University of Michigan Medical School 2004
Yale University (Masters of Health Science) 2014
Career/Academic Appointments:
2004-05
Intern, Internal Medicine, California Pacific Medical Center, San Francisco, CA
2005-2009
Resident and Chief Resident, Radiation Oncology, Yale New Haven Hospital, New
Haven, CT
2009-2015
Assistant Professor, Radiation Oncology, Yale University School of Medicine, New
Haven, CT
2015-present Associate Professor, Radiation Oncology, Yale University School of Medicine, New
Haven, CT
Administrative Positions:
2010-present Director of Continuing Medical Education, Department of Therapeutic Radiology, Yale
School of Medicine, New Haven, CT
2009-present Director, Genitourinary Radiation Oncology, Department of Therapeutic Radiology,
Yale University School of Medicine, New Haven, CT
2011-2015
Director, Central Nervous System Radiation Oncology, Department of Therapeutic
Radiology, Yale University School of Medicine, New Haven, CT
2011-present Co-Director, Yale Gamma Knife Program, Department of Therapeutic Radiology, Yale
School of Medicine, New Haven, CT.
Board Certification:
American Board of Radiology, Radiation Oncology, 2010
Professional Honors & Recognition
International/National/Regional
2013: Certificate of Excellence in Reviewing – Practical Radiation Oncology
2013: Certificate of Excellence in Reviewing – International Journal of Radiation, Oncology,
Biology, and Physics
2012: Outstanding Reviewer of 2012 – International Journal of Radiation, Oncology, Biology, and
Physics
2009: American Brachytherapy Society Seattle Prostate Brachytherapy Fellowship
2008: Young Oncologist Essay Award- American Radium Society
2004: University of Michigan Medical School Commencement – Class Speaker
University
2013: Association of Residents in Radiation Oncology Educator of the Year – Yale
2013: Yale Cancer Center Population Research Prize
Revised by Office for Faculty Affairs 05-03-2013
1
James B. Yu MD MHS
Grant/Clinical Trials History:
Current Grants
Agency: NIH/NCI
I.D.#
R01 CA190017-01
Title:
Impact of Social Contagion on Physician use of Unproven Cancer Interventions
P.I.:
Cary P. Gross MD
Role on project: Co-Investigator
Percent effort: 0-10%
Total costs for the project period: $300,000 per year
Project Period: 9/1/14-9/30/18
Agency: PhRMA Foundation
I.D.#
Assessing the Benefits of Treating Cancer Research Starter Grant
Title:
“Quantifying the benefit of modern cancer therapy for elderly patients: A population level
measurement”
P.I.:
James B. Yu M.D. MHS
Percent effort:
10%
Total costs for project period: $100,000
Project period:
09/01/2014 – 9/01/2015
Current Clinical Trials
Agency: Yale Department of Therapeutic Radiology
I.D.# HIC#1306012291
Title:
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3 Tesla
MRI and Rational Dose Selection
Role:
Principal Investigator
Percent effort: 0%
Total costs for project period: 0
Project period:
4/1/14- Ongoing
Past Grants
Agency: YCCI / NCATS
I.D.#
KL2 RR024138: SRS for Older Cancer Patients with Early Stage Non-Small-Cell Lung Cancer:
National patterns of care and comparison with surgery
Title:
: SRS for Older Cancer Patients with Early Stage Non-Small-Cell Lung Cancer: National
patterns of care and comparison with surgery
P.I.:
James B. Yu MD
Percent effort:
75%
Total costs for project period: $230,000
Project period:
07/01/2012 – 06/30/2014
Agency: NIH/NCI
I.D.#
R01-CA149045
Title:
“Use and outcomes of radiation therapy for Medicare patients with common cancers”
P.I.:
Cary P. Gross MD
Role on project: Co-Investigator
Revised by Office for Faculty Affairs 05-03-2013
2
James B. Yu MD MHS
Percent effort: 0-10%
Total costs for project period: $936,000
Project period: 04/01/10 – 4/01/13
Agency: NIH/NCI
I.D.#
R03-CA151153-01
Title:
“Racial disparities in clinical outcomes and the therapeutic use of radiotherapy for patients
with cutaneous lymphoma”
P.I.:
Lynn Wilson MD
Role on project: Co-Investigator
Percent effort: 5%
Total costs for project period: $82,750
Project period: 07/01/10 – 8/01/11
Agency: American Cancer Society
I.D.#
IRG-58-012-52
Title:
“The PICK Prostate Trial: Prostate Intensity Modulated Radiation Therapy versus
Cyberknife (PICK) Health Related Quality of Life (HRQoL) Trial”
P.I.:
James B. Yu MD
Percent effort: 10% (0 calendar months support)
Total costs for project period: $30,000
Project period: 07/01/10 – 9/30/11
Agency: RSNA Research and Education Foundation
I.D.#
IRG-58-012-52
Title:
“the PICK Prostate Trial: Prostate Intensity Modulated Radiation Therapy versus Cyberknife
(PICK) Health Related Quality of Life (HRQoL) Trial”
P.I.:
James B. Yu MD
Percent effort: 10% (0 calendar months support)
Total costs for project period: $30,000
Project period: 07/01/10 – 8/01/11
Invited Speaking Engagements, Presentations, Symposia & Workshops Not Affiliated With Yale:
International/National
2015: Impact of New Technology Diffusion on Medicare Expenditures - Appropriate use of Advanced
Technologies for Radiation Therapy and Surgery. Institute of Medicine – National Cancer Policy Forum
– Board on Health Care Services Workshop. July 20-21, 2015.
2014: Understanding the new evidence: A comparative effectiveness research primer for the radiation
oncologist. American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, CA.
September 14, 2014.
2014: Difficult cases in CNS Cancers. American Society of Radiation Oncology (ASTRO) Annual
Meeting, San Francisco, CA. September 15, 2014.
2014: Prostate Cancer: Comparative Effectiveness. The Council of Affiliated Regional Radiation
Oncology Societies (CARROS) Program. Saturday, September 13, 2014. San Francisco, CA.
2013: Difficult cases in CNS Cancers. American Society of Radiation Oncology (ASTRO) Annual
Meeting, Atlanta, GA. September 25, 2013.
Revised by Office for Faculty Affairs 05-03-2013
3
James B. Yu MD MHS
2012: Cancer Emergencies. American Society of Radiation Oncology (ASTRO) Annual Meeting.
Boston, MA. October 29, 2012
2011: Cancer Emergencies. American Society of Radiation Oncology (ASTRO) Annual Meeting.
Miami, FL. October 2-6, 2011.
2010: Cancer Emergencies. American Society of Radiation Oncology (ASTRO) Annual Meeting. San
Diego, CA. November 4, 2010.
Regional
2014: Comparative Effectiveness in Radiation Oncology. Radiation Oncology Grand Rounds. North
Shore-LIJ Health System. October 31, 2014.
2014: Lecture on Health Outcomes Research in Radiation Oncology. Visiting professor. Georgetown
University Department of Radiation Medicine. August 14, 2014.
2014: Lecture on Management of Brain Metastasis. Visiting professor. Georgetown University
Department of Radiation Medicine. August 14, 2014.
2014: Evaluating the Comparative Effectiveness of Prostate Radiotherapy. Yale/Rockefeller University
Collaborative Research Day – Oral Presentation. Rockefeller University Campus. June 19, 2014.
2012: Controversies in Prostate Cancer: Screening, Protons, and Bending of the Cost Curve.
Distinguished Visiting Professor Grand Rounds. UMDNJ/RWJ Radiation Oncology. December 4,
2012.
2009: Radiation Oncology Research and the SEER-Medicare Database. UMDNJ-RWJ Radiation
Oncology Research Monthly Grand Rounds, New Brunswick, NJ. October 27, 2009.
Peer-Reviewed Presentations & Symposia Given at Meetings Not Affiliated With Yale
International/National
(First Author Oral Presentations or Poster Discussion Sections at International / National
Meetings Only – Full list of presentations available upon request)
2014: American Society of Radiation Oncology (ASTRO) Annual Meeting. San Francisco, CA.
“Comparative effectiveness of stereotactic body radiotherapy vs. surgery for stage I Non-Small Cell
Lung cancer.”
2013: American Society of Radiation Oncology (ASTRO) Annual Meeting. Atlanta, GA. “Stereotactic
radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of early toxicity.”
Poster Discussion
2012: American Society of Radiation Oncology (ASTRO) Annual Meeting. Boston, MA. “Proton
Radiotherapy For Prostate Cancer In The Medicare Population: Patterns Of Care And Comparison Of
Early Toxicity With Intensity Modulated Radiotherapy.”
2009: American Radium Society Annual Meeting, Vancouver, BC. “Validating the Partin Tables using
the NCI SEER Database.”
2008: Radiological Society of North America 2008 Annual Meeting, Chicago, IL. “For patients with
prostate cancer, primary Gleason 5 portends an even worse prognosis compared to a primary pattern of 4
in patients with a total Gleason score of 9.”
2008: American Radium Society 2008 Annual Meeting, Laguna Niguel, CA. “Post-mastectomy
radiation therapy for node-negative, locally advanced breast cancer after modified radical mastectomy:
Analysis of the NCI Surveillance, Epidemiology, and End Results Database”
2007: Radiological Society of North America 2007 Annual Meeting, Chicago, IL. “NCI Surveillance
Epidemiology and End Results (SEER) Analysis of Sebaceous Carcinoma of the Skin.”
2007: Annual Meeting of the American Radium Society, Amsterdam, Netherlands. “Treatment of
Primary Cutaneous CD 30+ Anaplastic Large T-Cell Lymphoma with Localized Radiation Therapy.”
Revised by Office for Faculty Affairs 05-03-2013
4
James B. Yu MD MHS
Professional Service
Peer Review Groups/Grant Study Sections:
2014
Reviewer – Veterans Administration Evidence-based Synthesis Program (ESP) draft
report VAESP-D-14-00017, “Effectiveness and Harms of Proton Irradiation Treatment”.
2014
Member, American Society of Radiation Oncology (ASTRO) Comparative Effectiveness
Grant – Study Section
2013
Member, Radiological Society of North America (RSNA) Research and Education
Foundation – Radiation Oncology Study Section
2013
Member, American Society of Radiation Oncology (ASTRO) Comparative Effectiveness
Grant – Study Section
Journal Service:
Editor/Associate Editor
2014 – Senior Editor, Practical Radiation Oncology
January, 2014 – Member of the editorial board- Journal of Clinical Oncology
2014 – Member of the editorial board- Frontiers in Radiation Oncology
2012 – Member of the editorial board- Journal of Surgical Oncology (Radiation Oncology section)
2011 – Member of the editorial board- Oncology (Williston Park)
Reviewer
2009-present Ad Hoc reviewer for: Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology,
Int J Radiat Oncol Biol Phys, Diseases of the Esophagus, Journal of the American College of Surgeons,
Journal of Gastroenterologic Oncology, Yonsei Medical Journal, Journal of Thoracic Oncology,
Practical Radiation Oncology, Journal of Urology, Annals of Oncology, American Journal of Clinical
Oncology, Nature Reviews Urology, Journal of Geriatric Oncology, The Medical Letter. Expert
reviewer for the VA Evidence-based Synthesis Program.
Professional Service for Professional Organizations:
2014- present Vice Chairman - ASTRO Science Advisory Committee (Clinical, Translational and Basic
Science Committee)
2014- present Member – NRG Oncology Cancer Care Delivery Research (CCDR) Committee
2014-2015
Member – Joint ASCO/ASTRO/ACS Collaborative Study to examine geographic access
to cancer services.
2013- present Member – ASTRO Science Advisory Committee (Clinical, Translational and Basic
Science Committee)
2012-2013
Member - Health Service Research Committee, ASTRO
Meeting Planning/Participation
2014- present Member – Radiation Oncology Subcommittee of the Education Exhibits Committee
(EEC), RSNA
2014- present Track Chair – CNS – Annual Meeting Education Committee, ASTRO
2014- present Track Chair – Health Services Research – Annual Meeting Committee, ASTRO
2012- present Member – Annual Meeting Education Committee, ASTRO
2015- present Abstract Reviewer – Health Services Research, ASTRO Annual Meeting
2014
Moderator – Parallel General Scientific Session, Malignant Tumors, Leksell Gamma
Knife Meeting 2014
2013
Discussant, Health Services Research Scientific Session, ASTRO 2013 Annual Meeting
Revised by Office for Faculty Affairs 05-03-2013
5
James B. Yu MD MHS
2012-2014
2009-2011
2011
Abstract Reviewer – Genitourinary Malignancies, ASTRO Annual Meeting
Abstract Reviewer – Central Nervous System Malignancies, ASTRO Annual Meeting
Moderator, Palliative Care Scientific Session, ASTRO 2010 Annual Meeting
Yale University Service:
University Committees
2010-Present
Pierson College Fellow
2010-11
Pierson Freshman Advisor
Medical School Committees
None
Departmental Committees
2010-2011
Co-Chairman, Quality Initiatives Committee, Department of Therapeutic Radiology,
Yale School of Medicine, New Haven, CT.
Hospital Boards & Committees
2014
Member, Brain Metastases Task Force, Yale Cancer Center
Public Service:
2014: Yale Symposium: Radiosurgery Symposium. Radiosurgery for 1-4 and 5+ brain metastases.
2013: Yale Symposium: The Evolution of Multidisciplinary Management of Brain Metastases.
Stereotactic Radiosurgery as First-line Therapy for Multiple Brain Metastases.
2013: Yale Cancer Center Grand Rounds. Prostate cancer and the bending of the Cost Curve.
2009: Yale Prostate Cancer Symposium. Therapeutic Radiology.
2009: New England Society of Radiation Therapists Annual Meeting. Adult Gliomas.
2008: New England Society of Radiation Therapists Annual Meeting. Brain Metastases.
2007: New England Society of Radiation Therapists Annual Meeting. Pancreatic Carcinomas.
Bibliography:
Peer-Reviewed Original Research
1.
Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG, Griffin LB, Yu J,
Coppola JM, Giordano TJ, Lin L, Adams D, Orringer MB, Ross BD, Beer DG, and Rehemtulla A.
Phosphorylated FADD induces NF-kB, perturbs cell cycle, and is associated with poor outcome in
lung adenocarcinomas. Proc. Natl. Acad. Sci., 2005;102:12507-12512. PMID 16109772.
2.
Yu JB, Shiao SL, Knisely JP. A dosimetric evaluation of conventional helmet field irradiation
versus two-field intensity-modulated radiotherapy technique. Int J Radiat Oncol Biol Phys.
2007;68:621-631. PMID 17276616.
3. Wilson LD, Yu JB, Haffty BG. National residency matching program (NRMP) results for
radiation oncology: 2007 update. Int J Radiat Oncol Biol Phys. 2007;69:326-327. PMID
17869658.
4. Yu JB, Decker RH, Knisely JPS. The Role of Post-Operative Beam Radiation (PORT) in the
Treatment of Extrahepatic Bile Duct Cancer: A Surveillance, Epidemiology, and End Results
(SEER) Population Based Investigation. J Gastrointest Cancer. 2008;39:11-21. PMID 19156542.
5. Yu JB, Blitzblau RC, Decker RH, Housman DM, Wilson LD. Analysis of primary CD30+
Cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End
Results (SEER) database. J Clin Oncol. 2008;26:1483-1488. PMID 18349400.
Revised by Office for Faculty Affairs 05-03-2013
6
James B. Yu MD MHS
6.
Yu JB, McNiff JM, Lund MW, Wilson LD. Treatment of primary cutaneous CD30+ anaplastic
large cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys. 2008;70:1542-1545.
PMID 18037577.
7. Yu JB, Wilson LD, Dasgupta T, Castrucci WA, Weidhaas JB. Post-mastectomy radiation therapy
for node-negative, locally advanced breast cancer after modified radical mastectomy: Analysis of
the NCI Surveillance, Epidemiology, and End Results Database. Cancer. 2008;113:38-47. PMID
18442108.
8. Yu JB, Wilson LD, Detterbeck FS. Superior Vena Cava Syndrome – A Proposed Classification
System and Algorithm for Management. J Thoracic Oncology. 2008;3:811-814. PMID 18670297.
9. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma.
Cancer. 2009:115:158-165. PMID 18988294.
10. Yu JB, Khan AM, Jones GW, Reavely MM, Wilson LD. Patient Perspectives Regarding the
Value of Total Skin Electron Beam Therapy for Cutaneous T-Cell Lymphoma / Mycosis
Fungoides – A Pilot Study. Am J Clin Oncol. 2009;32:142-4. PMID 19307950.
11. Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy
versus Intensity Modulated Radiation Therapy in the management of localized Prostate
Adenocarcinoma. Radiother Oncol. 2009;93:185-91. PMID 19800702.
12. Aizer AA, Yu JB, McKeon AM, Decker RH, Colberg JW, Peschel RE. Whole pelvic radiation
therapy versus prostate only radiation therapy in the management of locally advanced or
aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys. 2009;1344-9. PMID 19464821.
13. Yu JB, Makarov DV, Sharma R, Peschel RE, Partin AW, Gross CP. Validation of the Partin
Nomogram for prostate cancer in a national sample. J Urol. 2010;183:105-11. PMID 19913246.
14. Lloyd S, Yu JB, Ross DA, Wilson LD, Decker RH. A Prognostic Index for Predicting Lymph
Node Metastasis in Minor Salivary Gland Cancer. Int J Radiat Oncol Biol Phys. 2010;76:169-75.
PMID 19386433.
15. Urdaneta AI, Yu JB, Wilson LD. Population Based Cancer Registry Analysis of Primary Tracheal
Carcinoma. Am J Clin Oncol. 2011;34:32-7. PMID 20087156.
16. Yu JB, Decker RH, Detterbeck FC, Wilson LD. SEER Evaluation of the Role of Surgery for
Stage I Small Cell Lung Cancer. J Thorac Oncol. 2010;5:215-9. PMID 20101146.
17. Yu JB, Blitzblau RC, Patel SC, Decker RH, Wilson LD. Surveillance, Epidemiology, and End
Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct
Carcinoma) of the Skin. Am J Clin Oncol. 2010;33:125-7. PMID 19675445.
18. Lesser RL, Knisely JPS, Wang SL, Yu JB, Kupersmith MJ. Long-term response to fractionated
radiotherapy of presumed optic nerve sheath meningiomas. Br J Ophthalmol. 2010;94:559-63.
PMID 19965820.
19. Aizer AA, Anderson NS, Oh SC, Yu JB, McKeon AM, Decker RH, Peschel RE. The impact of
pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients
treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;79:379-384.
PMID 20452135.
20. Yu JB, Makarov DL, Gross CP. A New Formula for Prostate Cancer Lymph Node Risk. Int J
Radiat Oncol Biol Phys. 2011;80:69-75. PMID 20594769.
21. Galper SA, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, Marcus KJ, Stevensen MA,
Chen MH, Ng AK. Clinically-significant cardiac disease in patients with Hodgkin Lymphoma
treated with mediastinal irradiation. Blood. 2011;117:412-418. PMID 20858859.
22. Schreiber D, Rineer R, Yu JB, Olsheski M, Nwokedi E, Schwartz D, Choi K, Rotman M.
Analysis of pathologic extent of disease for clinically localized prostate cancer after radical
prostatectomy and subsequent use of adjuvant radiation in a national cohort. Cancer.
2010;116:5757-66. PMID 20737571.
Revised by Office for Faculty Affairs 05-03-2013
7
James B. Yu MD MHS
23. Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic
carcinoma of the head and neck including an analysis of adjuvant radiation therapy. Am J Clin
Oncol. 2011;34:76-81. PMID 20177363.
24. Makarov DV, Yu JB, Desai R, Penson D, Gross C. The association between diffusion of the
surgical robot and radical prostatectomy rates. Med Care. 2011;49:333-9. PMID 21368677.
25. Anderson NS, Patel R, Yu JB, Peschel RE, Decker RH. A significant decrease in rectal volume
and diameter during prostate cancer IMRT. Radiother Oncol. 2011;98:187-91. PMID 21269715.
26. Aneja S, Wilson LD, Haffty BG, Yu JB. National residency matching program (NRMP) results
for radiation oncology: 2010 Update. Int J Radiat Oncol Biol Phys. 2011;80:4-5. PMID
21481720.
27. Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts KB, Yu JB. A geographic
analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys. 2012;82:1723-9.
PMID 21493013.
28. Deng J, Chen Z, Yu JB, Roberts KB, Peschel RE, Nath R. Testicular doses in image-guided
radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:e39-47. PMID
21489702.
29. Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Penson DF, Gross CP.
The Population Level Prevalence and Correlates of Appropriate and Inappropriate Imaging to
Stage Incident Prostate Cancer in the Medicare Population. J Urol. 2012;187:97-102. PMID
22088337.
30. Park HS, Gross CP, Makarov DV, Yu JB. Immortal Time Bias: A Frequently Unrecognized
Threat to Validity in the Evaluation of Postoperative Radiation Therapy. Int J Radiat Oncol Biol
Phys. 2012;83:1365-73. PMID 22342097.
31. Buscariollo D, Park H, Roberts KB, Yu JB. Survival outcomes in atypical teratoid rhabdoid tumor
for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.
Cancer. 2012;118:4212-9. PMID 22213196.
32. Raldow A, Presley C, Yu J, Sharma R, Cramer L, Soulos P, Long J, Makarov D, Gross C. The
relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch
Intern Med. 2012;172:362-3. PMID 22371925.
33. Flanigan JC, Jilaveanu LB, Faries M, Sznol M, Ariyan S, Yu JB, Knisely JP, Chiang VL, Kluger
HM. Melanoma brain metastases: Is it time to reassess the bias? Curr Probl Cancer. 2011;35:200210. PMID 21911183.
34. Yu JB, Soulos PR, Sharma R, Makarov DV, Decker RH, Smith BD, Desai RA, Cramer LD, Gross
CP. Patterns of Care and Outcomes Associated with Intensity Modulated Radiation Therapy versus
Conventional Radiation Therapy for Older Patients with Head and Neck Cancer. Int J Radiat
Oncol Biol Phys. 2012;83:e101-7. PMID 22342095.
35. Raldow AC, Chiang VL, Knisely JP, Yu JB. Survival and intracranial control of patients with 5 or
more brain metastases treated with gamma knife stereotactic radiosurgery. Am J Clin Oncol. 2013:
36:486-90. PMID 22706180.
36. Soulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, Gross CP. Assessing the impact
of a cooperative group trial on breast cancer care in the Medicare population. J Clin Oncol.
2012;30:1601-7. PMID 22393088.
37. Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Krumholz HM, Penson
DF, Gross CP. Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by
region, as if set by thermostat. Health Affairs. 2012;31:730-40. PMID 22492890.
38. Aneja S, Wilson LD, Haffty BG, Yu JB. National Residency Matching Program (NRMP) Results
For Radiation Oncology: 2011 Update. Accepted for publication. Int J Radiat Oncol Biol Phys.
2012;83:771-2. PMID 22633550.
Revised by Office for Faculty Affairs 05-03-2013
8
James B. Yu MD MHS
39. Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VLS. Radiosurgery for Melanoma
Brain Metastases in the Ipilimumab Era: Longer Survival is Possible. J Neurosurg. 2012;117:22733. PMID 22702482.
40. Evans S, Yu JB, Chagpar A. How Radiation Oncologists Would Disclose Error: Results of a
Survey of Radiation Oncologists and Trainees. Int J Radiat Oncol Biol Phys. 2012;84:e131-7.
PMID 22560545.
41. Lloyd S, Yu JB, Wilson LD, Judson BL, Decker RH. The prognostic importance of midline
involvement in oral tongue cancer. Am J Clin Oncol. 2012;35:468-73. PMID 21701377.
42. Aneja S, Yu JB. The Impact of County-Level Radiation Oncologist Density on Prostate Cancer
Mortality in the United States. Prostate Cancer and Prostatic Diseases. 2012 Jul 24. Epub ahead of
print. PMID 22824828.
43. Wilson LD, Hinds GA, Yu JB. Age, Race, Gender, Stage, and the Incidence of Cutaneous
Lymphoma. Clin Lymph Myel Leuk. 2012;12:291-6. PMID 23040434
44. Presley C, Raldow A, Cramer L, Soulos P, Long J, Yu JB, Makarov D, Gross CP. Overtreatment,
Undertreatment, and Racial Disparities among Older Men with Localized Prostate Cancer. J
Geriatric Oncol. 2013;4:1-8. PMID 23828723.
45. Quon JL, Yu JB, Soulos PR, Gross CP. The relation between age and androgen deprivation
therapy use among men in the Medicare population receiving radiation therapy for prostate cancer.
J Geriatric Oncol. 2013;4:9-18. PMID 23482846.
46. Jairam V, Roberts KB, Yu JB. Historical trends in the use of radiation therapy for pediatric
cancers: 1973-2008. Int J Radiat Oncol Biol Phys. 2013; 85:e151-5. PMID 23273995.
47. Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B, Lesnikoski BA, Long JB, Gross
CP. Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National
Medicare Population From 2008-2009. J Clin Oncol. 2012;30:4302-7. PMID 23091103. PMCID
PMC3675700.
48. Yu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP. Proton versus
Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity. JNCI.
2013;105:25-32. PMID 23243199.
49. Feinstein AJ, Soulos PR, Long JB, Herrin J, Roberts KB, Yu JB, Gross CP. Variation in Receipt
of Radiation Therapy After Breast-conserving Surgery: Assessing the Impact of Physicians and
Geographic Regions. Med Care. 2012; Nov 12. Epub Ahead of Prin. [PMID 23151590].
50. Roberts KB, Soulos PR, Jerrin J, Yu JB, Long JB, Dostaler E, Gross CP. The adoption of new
adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: Clinical
correlates and cost implications. Int J Radiat Oncol Biol Phys. 2012; Nov 21. Int J Radiat Oncol
Biol Phys. 2013;85:1186-92. PMID 23182396. PMCID PMC3606652.
51. Jairam V, Chiang VLS, Yu JB, Knisely JPS. Role of stereotactic radiosurgery in patients with
more than 4 brain metastases. CNS Oncology. 2013;2:181-93. PMID 24273642,
52. Aneja S, Wilson LD, Haffty BG, Yu JB. National Residency Matching Program (NRMP) Results
for Radiation Oncology: 2012 Update. Int J Radiat Oncol Biol Phys. 2013;86:402-404. PMID
23708083.
53. Aneja S, Khullar D, Yu JB. The Influence of Regional Health System Characteristics on the
Surgical Management and Receipt of Post Operative Radiation Therapy for Glioblastoma
Multiforme. Journal of Neurooncology. Accepted for Publication. 2013. PMID 23412775.
54. Moreno AC, Morgensztern D, Yu JB, Boffa DJ, Decker RJ, Detterbeck FC, Kim AW. Impact of
preoperative radiation on survival of patients with T3N0 > 7-cm non-small cell lung cancers
treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. J
Surg Res. 2013 Apr 3. PMID 23583079.
Revised by Office for Faculty Affairs 05-03-2013
9
James B. Yu MD MHS
55. Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB. Determinants of enrollment in cancer
clinical trials: The relationship between the current state of knowledge, societal disease burden,
and randomized clinical trial enrollment. JNCCN. JNCCN. 2013;11:928-36. PMID 23947162.
56. Kim SP, Tilburt JC, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB,
Trinh QD, Sun M, O’Malley RL, Nguyen PL. Variations in treatment recommendations for
adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology.
2013;82:801-12. PMID 23910088.
57. Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski BA, Ross JS, Krumholz HM, Gross
CP. For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.
Surgery. 2014;155:776-88. PMID 24787104.
58. Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Yu JB, Makarov DV, Gross CP. A new
approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol.
2013;4:1-8. PMID 23828723. PMCID PMC3697868.
59. Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Decker RJ, Hess JA, Chiang VL, Contessa JN. A
clinical model for identifying radiosensitive genotypes in non-small cell lung cancer. Clin Canc
Res. 2013. 2013;19:5523-32. PMID 23897899.
60. Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The cost
implications of prostate cancer screening in the Medicare population. Cancer. 2014;120:96-102.
PMID 24122801.
61. Wang C, Bindra R, Roberts KB, Chiang VC, Yu JB. Delayed cerebral vasculopathy due to cranial
radiation therapy for pediatric tumors. Pediatric Neurology. 2014;50:549-56. PMID 24739378.
62. Batouli A, Jahanshahi P, Gross C, Makarov DV, Yu JB. The global cancer divide: Relationships
between national healthcare resources and cancer outcomes in developed vs. developing countries.
J Epid Global Health. 2014;4:115-24. PMID 24857179.
63. Sen S, Wang S, Soulos P, Frick K, Long J, Roberts K, Yu JB, Evans S, Chagpar A, Gross CP.
Examining costs and value of radiation therapy modalities among older women with favorable risk
breast cancer. JNCI. 2014;106(3). Epub 2014 Mar 5. PMID 24598714.
64. Lloyd S, Dosoretz AP, Yu JB, Evans SB, Decker RH. Academic and Resident Radiation
Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life. Am J
Clin Oncol. 2014 Jan 2. PMID 24390273.
65. Sheehan JP, Starke RM, Kano H, Kaufman A, Mathieu D, Zeiler F, West M, Chao S, Varma G,
Chiang VLS, Yu JB, McBride H, Nakaji P, Youssef E, Honea N, Rush S, Konziolka D, Lee J,
Bailey RL, Kunwar S, Petti P, Lunsford LD. Gamma knife radiosurgery for sellar and parasellar
meningiomas: A multicenter study. J Neurosurg. 2014;120:1268-77. PMID 24678777.
66. Nath SK, Yu JB, Wilson LD. Poorer prognosis of African-Americans with Mycosis Fungoides: an
Analysis of the SEER Dataset, 1988-2008. Clin Lymph Myl Leuk. 2014. 2014;14:419-23. PMID
24508350.
67. Nath SK, Sheridan AD, Rauch PJ, Yu JB, Minja FJ, Vortmeyer AO, Chiang VL. Significance of
histology in determining management of lesions regrowing after radiosurgery. J Neurooncol.
2014;117:303-10. PMID 24504499.
68. Yu JB, Cramer LD, Herrin J, Soulos PR, Potoskly AL, Gross CP. Stereotactic body radiotherapy
versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity. J Clin Oncol.
2014;32:1195-201. PMID 24616315.
69. Han L, Deple S, Shah ND, Ziegenfuss JY, Tilburt JC, Karnes RJ, Nguyen PY, Gross CP, Yu JB,
Trinh QD, Sun M, Kim SP. Perceptions of radiation oncologists and urologists on sources and type
of evidence to inform prostate cancer treatment decisions. Int J Radiat Oncol Biol Phys.
2014;89:277-83. PMID 24685153.
70. Yang DX, Soulos PR, Gross CP, Yu JB. Estimating the magnitude of colorectal cancers prevented
during the era of screening. Cancer. 2014;120:2893-901. PMID 24894740.
Revised by Office for Faculty Affairs 05-03-2013
10
James B. Yu MD MHS
71. Lester-Coll NH, Dosoretz AP, Yu JB. A decision analysis of stereotactic radiosurgery versus
stereotactic radiosurgery and whole brain radiation therapy for one to three brain metastases. Int J
Radiat Oncol Biol Phys. 2014;89:563-8. PMID 24751412.
72. Wang S, Wang R, Yu J, Ma X, Xu X, Kim S, Soulos PR, Saraf A, Gross CP. Understanding
Regional Variation in Medical Expenditures for Initial Episodes of Prostate Cancer Care. Med
Care. 2014;52:680-7. PMID 25023913.
73. Yeboa DB, Xu X, Jones BA, Soulos P, Gross CP, Yu JB. Trend in age and racial disparities in the
receipt of post-lumpectomy radiation therapy for stage I breast cancer: 2004-2009. Accepted for
publication. Am J Clin Oncol. 2014 May 29. [Epub ahead of print]. PMID 24879475.
74. Starke R, Kano H, Ding D, Nakaji P, Barnett GH, Mathieu D, Chiang V, Yu JB, Hess J, McBride
HL, Honea N, Lee JY, Rahmathulla G, Evanoff WA, Alonso-Basanta M, Lunsford LD, Sheehan
JP. Stereotactic radiosurgery of petroclival meningiomas: A multicenter study. J Neurooncol. 2014
May 13 [Epub ahead of Print]. PMID: 24821284.
75. Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG,
Kim AW. Treating locally advanced disease: an analysis of very large, hilar lymph node positive
non-small cell lung cancer using the National Cancer Database. Ann Thorac Surg.
2014;97:1149055. PMID 24582015.
76. Wang EH, Mougalian SS, Soulos PR, Rutter CE, Evans SB, Haffty BG, Gross CP, Yu JB. The
adoption of hypofractionated whole breast irradiation for early-stage breast cancer: A national
cancer database analysis. Int J Radiat Oncol Biol Phys. 2014 Aug 19 [Epub ahead of print]. PMID
25149661.
77. Wang EH, Yu JB, Gross CP, Smaldone MC, Shah ND, Trinh QD, Sun M, Han LC, Weight CJ,
Kim SP. Variation in pelvic lymph node dissection undergoing radical prostatectomy by hospital
characteristics and surgical approach: Results from the National Cancer Database. J Urol. 2014
Sept 18. Epub ahead of print. PMID 25242393.
78. Jairam V, Yu JB, Aneja S, Wilson LD, Lloyd S. Differences in funding sources of phase III
oncology clinical trials by treatment modality and cancer type. Am J Clin Oncol. 2014. Nov 4.
[Epub ahead of print]. PMID 25374144.
79. Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu
JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC. Perceptions of active surveillance and treatment
recommendations for low-risk prostate cancer: Results from a national survey of radiation
oncologists and urologists. Med Care. 52;579:85. PMID 24926704.
80. Wang EH, Mougalian S, Soulos PR, Smith BD, Haffty BG, Gross CP, Yu JB Adoption of
intensity-modulated radiotherapy use for early-stage breast cancer from 2004 through 2011. Int J
Radiat Oncol Biol Phys. 2014; Aug 19. [Epub ahead of print]. PMID 25149661.
81. Rutter CE, Yu JB, Carlson DJ, Husain ZA, Zhao S, Picone J, Bindra RS. Reirradiation of
recurrent intramedullary spinal cord metastases: A clinical dilemma. Journal of Radiosurgery and
SBRT. 2014;3(2): 165-8.
82. Maroongroge S, Dosoretz AP, Kim SP, Gross CP, Yu JB. Revisiting the SGR “hole”: Sources of
health care cost stabilization in 2010-2012. Int J Radiat Oncol Biol Phys. 2014;90:983-5.
83. Corso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT
Clinical Practice Patterns. Am J Clin Oncol. 2014 Dec 10 [Epub ahead of print]. PMID 25503436.
84. Park HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients with
Locally Advanced Non-Small Cell Lung Cancer at High Risk for Brain Metastases. Clinical Lung
Cancer. 2014 Nov 22. [Epub ahead of print]. PMID 25499149.
85. Jairam V, Bond J, Chiang VLS, Yu JB. Equivalent whole brain dose for patients undergoing
gamma knife for multiple lesions. J Radiosurgery and SBRT. 2015;3:187-191.
Revised by Office for Faculty Affairs 05-03-2013
11
James B. Yu MD MHS
86. Makarov DV, Soulos PR, Gold HT, Yu JB, Sen S, Ross JS, Gross CP. Regional-level Correlations
in Inappropriate Imaging Rates for Prostate and Breast Cancers. JAMA Oncology. Published
online March 12, 2015. PMID 26181021.
87. Sheehan JP, Starke RM, Kano H, Barnett GH, Mathieu D, Chiang C, Yu JB, Hess J, McBride HL,
Honea N, Nakaji P, Lee JY, Rahmathulla G, Evanoff WA, Alonso-Basanta M, Lunsford LD.
Gamma Knife Radiosurgery. Gamma knife radiosurgery for posterior fossa meningiomas: A
multicenter study. J Neurosurg. 2014;120:1268-77. PMID 24678777.
88. Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi D, Azodi M, Rutherford T, Schwartz
PE, Damast S. Adjuvant carboplatin, paclitaxel and vaginal cuff brachytherapy for stage III
endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic
characteristics. Int J Gynecol Canc. 2015;25:431-9. PMID 25621409.
89. Wang EH, Gross CP, Tilburt JC, Yu JB, Nguyen PL, Smaldone MC, Shah ND, Abouassally R,
Sun M, Kim SP. Shared decision making and use of decision aids for localized prostate cancer:
Perceptions from radiation oncologists and urologists. JAMA Intern Med. 2015 Mar 9. PMID
25751604.
90. Rutter CE, Yu JB, Wilson LD, Park HS. Assessment of national practice for palliative
radiotherapy for bone metastases suggests marked underutilization of single-fraction regimens in
the United States. Int J Radiat Oncol Biol Phys. 2015;91:548-55. PMID 25542310.
91. Campbell A, Glover J, Chiang VC, Gerrard J, Yu JB. Gamma knife stereotactic radiosurgical
thalamotomy for intractable tremor: A systematic review of the literature. Accepted for
publication. Radiother Oncol. 2015 Feb 14. PMID 25690750.
92. Wang E, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park H. Patients
selected for definitive concurrent chemoradiation at high-volume facilities achieve improved
survival in stage III non-small cell lung cancer. J Thorac Oncol. 2015 Feb 21. PMID 25738221.
93. Feinstein AJ, Long J, Soulos PR, Ma X, Herrin J, Frick KD, Chagpar AB, Krumholz HM, Yu JB,
Ross JS, Gross CP. Older women with localized breast cancer: costs and survival rates increased
across two time periods. Health Aff (Millwood). 2015;34:592-600.
94. Wang EH, Yu JB, Gross CP, Abouassaly R, Cherullo EE, Smaldone MC, Shah ND, Kiechle J,
Trinh QD, Sun M, Kim SP. Association between surgeon and hospital characteristics and lymph
node counts from radical prostatectomy and pelvic lymph node dissection. Urology. 2015;85:8905.
95. Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB.
Postoperative radiation therapy is associated with improved overall survival in incompletely
resected stage II and III non-small cell lung cancer. J Clin Oncol. 2015, Jun 22. PMID 26101240.
96. Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of
SBRT for treating early-stage lung cancer. Lung Cancer. 2015;89:133-8. PMID 26051446.
97. Sheehan et al. Gamma knife radiosurgery for facial schwannomas: A multicenter study. J
Neurosurg. 2015 May 8:1-8[Epub ahead of print]. PMID 25955875.
98. Yeboa DN, Aneja S, Gustavo M, Roberts KB, Yu J. Historical trends in radiotherapy use in
prevalent malignancies over 38 years in SEER. Journal of Radiation Oncology, 2015, DOI:
10.1007/s13566-015-0182-y
99. Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. The comparative effectiveness
of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121:2341-9.
PMID 25847699.
Chapters, Books, and Reviews
Revised by Office for Faculty Affairs 05-03-2013
12
James B. Yu MD MHS
100. Yu JB, Knisely JPS. Radiation Therapy for Brain Metastases, in Brain Metastases: A
Multidisciplinary Approach. Kleinberg LD(ed), Demos Medical Publishing, New York, NY 2009,
pp 27-60.
101. Yu JB, Knisely JPS. Prognosis of Patients with Brain Metastases Who Undergo Radiation
Therapy, in Brain Metastases: A Multidisciplinary Approach. Kleinberg LD(ed), Demos Medical
Publishing, New York, NY 2009, pp 61-76.
102. Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER Public use Data: Applications and
Limitations in Oncology Research. Oncology (Williston Park). 2009;23:288-95. PMID 19418830.
103. Raldow A, Hamstra DH, Kim SN, Peschel RE, Yu JB. Salvage radiotherapy for Prostate Cancer
after Radical Prostatectomy: Current Status and Controversy. Oncology (Williston Park).
2010;24:692-700, 702. PMID 20718248.
104. Park HS, Yu JB, Knisely JP, Chiang VLS. Outcomes following gamma knife for metastases. In
Tech Open Access. 2011.
105. Park HS, Chiang VL, Knisely JP, Raldow A, Yu JB. Stereotactic radiosurgery with or without
whole-brain radiotherapy for brain metastases: an update. Expert Rev. Anticancer Ther.
2011;11:1731-8. PMID 22050022.
106. Raldow A, Hamstra DH, Kim SN, Yu JB. Adjuvant Radiotherapy after Radical Prostatectomy:
Evidence and Analysis. Cancer Treatment Reviews. 2011;37:89-96. PMID 20667660
107. Aneja S, Gross CP, Soulos PR, Yu JB. Geographical Information Systems: Applications and
Limitations in Oncology Research. Oncology(Williston Park). 2011;25:1221-5.
108. Knisely JP, Schulder M, Yu JB. Radiosurgical dose selection for brain metastases. Prog Neuro
Surg. 2012:25;139-47. PMID 22236675.
109. Becker K, Yu JB. Status Quo – Standard of care Medical and Radiation Therapy of
Glioblastoma. Cancer J. 2012;18:12-19. PMID 22290252.
110. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the SEER Database: Evolution,
Data Variables, and Quality Assurance. Curr Probl Cancer. 2012;36:183-90. PMID 22481006.
111. Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Using the SEER Database to Investigate
Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and Outcomes. Curr
Probl Cancer.2012;36:191-9. PMID 22495057.
112. Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Prediction Models, Nomograms, and
Staging Validation with the SEER Database. Curr Probl Cancer. 2012;37:200-7. PMID 22481008.
113. Yu JB, Lloyd S, Decker RH, Wilson LD, Park HS. Comparative Effectiveness Research and the
SEER Database. Curr Probl Cancer. 2012;36:208-15. PMID 22481005.
114. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and Biases of the SEER
Database. Curr Probl Cancer. 2012;36:216-24. PMID 22481009.
115. Patel TR, Yu JB, Piepmeier JM. Role of neurosurgery and radiation therapy in the management
of brain tumors. Hem Onc Clin N Am. 2012;26:757-77. PMID 22794282.
116. Lacy J, Saadati H Yu JB. Complications of brain tumors and their treatment. Hem Onc Clin N
Am. 2012;26:779-96. PMID 22794283.
117. Aneja S Pratiwadi RR, Yu JB. Hypofractionated Radiation Therapy for Prostate Cancer: Risks
and Potential Benefits in a Fiscally Conservative Healthcare System. Oncology (Williston Park).
2012;26:512-8. PMID 22870533.
118. Yu JB, Efstathiou JA, Bekelman JE. Proton radiotherapy for prostate cancer: How did we get
here, and where do we go from here? Oncology (Williston Park). 2013;27:1293-4. PMID
24624550.
119. Jagsi R, Bekelman J, Chen A, Chen R, Hoffman K, Shi YT, Smith BD, Yu JB. Considerations
for observational research using large datasets in radiation oncology. Int J Radiat Oncol Biol Phys.
2014;90:11-24. PMID 25195986.
Revised by Office for Faculty Affairs 05-03-2013
13
James B. Yu MD MHS
120. Aneja S, Yu JB. Comparative effectiveness research in radiation oncology: Stereotactic
radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol. 2014; 24:35-42. PMID
24314340.
Peer-Reviewed Educational Materials
None
Invited Editorials and Commentaries
121. Yu JB, Weidhaas JB. Post-mastectomy radiation therapy for node-negative, locally advanced
breast cancer after modified radical mastectomy. Am J Hem Onc. March, 2009. (Invited
commentary).
122. Marsland T, Arena F, Yeilding A, Glode M, Ellis L, Yu J, Henderson C, Wagman L, Piver S,
Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W. Perspective on… the new PSA
screening recommendations. Oncology (Willison Park). 2011;25:1183, 1187-8, 1190. PMID
22229211.
123. Yu JB. Editorial: The American College of Radiology Appropriateness Criteria. Oncology
(Williston Park). 2013, August 1.
124. Yu JB. Interpreting cost-utility analysis of prostate cancer treatment. Nat Rev Urol.
2013;10:129-31.PMID 23399726.
125. Yu JB. Editorial:The daily miracle of palliative radiotherapy for prostate cancer. Oncology
(Williston Park). 2014;28:261.
126. Yu JB. Editorial: Breast cancer brain metastases: one step at a time. Oncology (Williston Park).
2014; 28:570.
127. Yu JB, Sandler H. Stereotactic body radiation therapy: Let’s not give up on progress. Practical
Radiation Oncology. 2014 Oct 14 [Epub ahead of print]. PMID 25413388.
128. Zhang Y, Feng Y, Zhang Y, Ming X, Yu J, Carlson D, Kim J, Deng J. Is it the time for
personalized imaging protocosl in cancer radiotherapy? Int J Radiat Oncol Biol Phys.
2015;91:659-60. PMID 25680605.
Practice Guidelines, Standards and Consensus Statements
129. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting
guidelines for thymic malignancies. J Thorac Oncol. 2011;6:S1743-S1748. PMID 21847057.
Case Reports, Technical Notes, Letters
130. Yu JB, Zelterman D, Decker RH, Knisely JPS. The Impact of Immediate Post-Operative Death
on the Estimation of a Survival Benefit from Post-Operative Radiation Therapy for Cancer of the
Gallbladder. (Correspondence). J Clin Oncol. 2008;26:4523; author reply 4524-6. PMID
18802172.
131. Knisely JPS, Yu JB. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique
using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard
to Gondi v, et Al. (Int j radiat oncol biol phys 2010;78:1244-1252). Int J Radiat Oncol Biol Phys.
2011 Mar 1;79(3):957-8. PMID 21281899.
132. Yu JB. In regard to "Indications for Pelvic Nodal Treatment in Prostate Cancer should Change.
Validation of the Roach Formula in a Large Extended Nodal Dissection Series". Int J Radiat Oncol
Biol Phys. 2012. 2012;83:481. PMID 22579472.
133. Damast S, Yu JB. Image IQ: What diagnosis do these brain imaging results point to? Oncology
(Williston Park). 2012;26:1231.
Revised by Office for Faculty Affairs 05-03-2013
14
James B. Yu MD MHS
134. Yu JB. Image IQ: A 45 Year-old Woman With an Incidental Finding on MRI. Oncology
(Williston Park). 2013.
135. Rutter C, Yu JB. Image IQ: Young Man with Blurred Vision and Headaches. Oncology
(Williston Park). 2013.
136. Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Gross CP. Reply to LW Cuttino et al. J
Clin Oncol.2013;31:2227-9. PMID 23901421.
137. Yu JB. Image IQ: Lower Back Pain in an Elderly Man With a History of Localized Prostate
Cancer. May 17, 2013.
138. Yu JB, Soulos PR, Herrin J, Cramer LD, Roberts KB, Gross CP. Response. JNCI.
2013;105:748-9. PMID 23814886.
139. Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP. Reply to K. Quan et al, S.P.
Collins et al, C.R. King et al, S. Arcangeli et al, D.B. Fuller, and D. Vordermark. J Clin Oncol.
2014 Sept 2. [Epub ahead of print]. PMID 25185090.
140. Yu JB. Image IQ: Brain CT Scan Shows “Spoke Wheel” Pattern Following Concussion. May
12, 2014.
Scholarship In Press
141. Park HS, Wang EH, Rutter C, Corso C, Chiang V, Yu JB. Changing patterns of gamma knife
versus linear accelerator-based stereotactic radiosurgery for brain metastases in the United States. J
Neurosurg. 2015. Accepted for publication.
142. Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D, Giordano S, Goldstein M,
Guadagnolo BA, Kosty M, Hopkins S, Yu JB, Arnone A, Hanley A, Stevens S, Hershman DL.
Association between geographic access to cancer care, insurance, and receipt of chemotherapy:
Geographic distribution of oncologists and travel distance. J Clin Oncol. 2015. Accepted for
publication.
143. Johung K, Yeh N, Desai N, Williams TM, Lautenschlaeger T, Arvold N, Attia A, Lovly C,
Goldberg S, Beal K, Yu JB, Kavanaugh B, Chiang V, Camidge DR, Contessa C. Extended
survival and prognostic factors for patients with ALK translocated NSCLC and brain metastases. J
Clin Oncol. 2015. Accepted for publication.
144. Mahal BA, Muralidhar V, Dinh KT, Chen YW, Nezolosky MD, Choueiri TK, Hoffman KE, Hu
JC, Sweeney CJ, Yu JB, Trinh QC, Nguyen PC. Gleason 5+3 = 8 prostate cancer: Much more like
Gleason 9?. BJU International. 2015. Accepted for publication.
Revised by Office for Faculty Affairs 05-03-2013
15